Idioma:

Tranilast, an antifibrotic agent and COVID-19-induced pulmonary fibrosis

Oshitani, N ; Watanabe, K ; Sakuma, T ; Matsuda, M ; Oyama, Y

QJM : An International Journal of Medicine, 2022-04, Vol.115 (4), p.249-250 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Tranilast, an antifibrotic agent and COVID-19-induced pulmonary fibrosis
Autor: Oshitani, N ; Watanabe, K ; Sakuma, T ; Matsuda, M ; Oyama, Y
Assuntos: Case Reports ; COVID-19 ; Fibrosis ; Humans ; ortho-Aminobenzoates - pharmacology ; ortho-Aminobenzoates - therapeutic use ; Pulmonary Fibrosis - drug therapy ; Pulmonary Fibrosis - etiology
É parte de: QJM : An International Journal of Medicine, 2022-04, Vol.115 (4), p.249-250
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Editor: England: Oxford University Press
Idioma: Inglês

Links

Voltar para lista de resultados